Key result
Thiazides and beta blockers impair glycemic control and glucose recovery in patients with diabetes.
Answers are grounded in this paper and cite their sources.
Many antihypertensive drugs have adverse effects on glycemic control when they are used in diabetic patients. This was noted for thiazide diuretics in 1960, and the mechanism of the effects remains uncertain. Indirect evidence suggests that changes in the serum potassium are at least contributory, although the principal mechanism of thiazide-induced hyperglycemia is probably a reduction in the insulin response to glucose. Beta blockers also adversely affect blood sugar control but only by a small margin. The main cause for concern with beta blockers, however, is their effect during hypoglycemia in which nonselective agents delay blood sugar recovery. In diabetic patients, the institution of antihypertensive therapy should be followed by a reassessment to note any changes in sugar, potassium, and lipids, or side effects.
No takes yet. Share an insight, caveat, or question.
Struthers et al. (1985) conducted a review in Diabetes mellitus and hypertension. Antihypertensive drugs (thiazide diuretics and beta blockers) was evaluated on Glycemic control / glucose tolerance. Thiazide diuretics and beta blockers adversely affect glycemic control and blood sugar recovery in diabetic patients, necessitating reassessment of glucose, potassium, and lipids after initiation.
Synapse has enriched 10 related papers. Consider them for comparative context: